Viswanath Gunda

2.8k total citations
29 papers, 1.3k citations indexed

About

Viswanath Gunda is a scholar working on Molecular Biology, Oncology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Viswanath Gunda has authored 29 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 10 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Viswanath Gunda's work include Thyroid Cancer Diagnosis and Treatment (6 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer-related Molecular Pathways (5 papers). Viswanath Gunda is often cited by papers focused on Thyroid Cancer Diagnosis and Treatment (6 papers), Ferroptosis and cancer prognosis (5 papers) and Cancer-related Molecular Pathways (5 papers). Viswanath Gunda collaborates with scholars based in United States, India and South Korea. Viswanath Gunda's co-authors include Sareh Parangi, Partha Roy, Jiansheng Huang, Li Wang, Salma Amin, Pierre Vanden Borre, Gordon J. Freeman, Benjamin J. Gigliotti, Bhavna Sharma and Rajani Salunke and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Viswanath Gunda

28 papers receiving 1.2k citations

Peers

Countries citing papers authored by Viswanath Gunda

Since Specialization

Citations

This map shows the geographic impact of Viswanath Gunda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Viswanath Gunda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Viswanath Gunda more than expected).

Fields of papers citing papers by Viswanath Gunda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Viswanath Gunda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Viswanath Gunda. The network helps show where Viswanath Gunda may publish in the future.

Co-authorship network of co-authors of Viswanath Gunda

This figure shows the co-authorship network connecting the top 25 collaborators of Viswanath Gunda. A scholar is included among the top collaborators of Viswanath Gunda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Viswanath Gunda. Viswanath Gunda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Combination BRAF ^V600E Inhibition with the Multitargeting Tyrosine Kinase Inhibitor Axitinib Shows Additive Anticancer Activity in BRAF ^V600E -Mutant Anaplastic Thyroid Cancer 2023 ·Thyroid ·Viswanath Gunda, Chandrayee Ghosh, Jiangnan Hu, Lisa Zhang, (unknown), Min Shen, Electron Kebebew	9
2	Abstract 5505: Combination nitazoxanide and auranofin treatment has synergistic anticancer activity in anaplastic thyroid cancer and act by enhanced activation of multiple cell death pathways 2023 ·Cancer Research ·Chandrayee Ghosh, Viswanath Gunda, Jiangnan Hu, Lisa Zhang, Yaqin Zhang, Min Shen, Electron Kebebew	0
3	Detecting Immune Response to Therapies Targeting PDL1 and BRAF by Using Ferumoxytol MRI and Macrin in Anaplastic Thyroid Cancer 2020 ·Radiology ·Thomas S.C. Ng, Viswanath Gunda, Ran Li, Mark Prytyskach, Yoshiko Iwamoto, Rainer H. Köhler, Sareh Parangi, Ralph Weissleder, Miles A. Miller	22
4	Mitochondrial superoxide disrupts the metabolic and epigenetic landscape of CD4+ and CD8+ T-lymphocytes 2019 ·Redox Biology ·(unknown), (unknown), Viswanath Gunda, Aparna Vasanthakumar, John Z. Cao, Pankaj K. Singh, Lucy A. Godley, Adam J. Case	27
5	Combinations of BRAF inhibitor and anti-PD-1/PD-L1 antibody improve survival and tumour immunity in an immunocompetent model of orthotopic murine anaplastic thyroid cancer 2018 ·British Journal of Cancer ·Viswanath Gunda, Benjamin J. Gigliotti, (unknown), (unknown), Michael C. McCarthy, Zhiheng Zhou, Salma Amin, Gordon J. Freeman, Alessandro Alessandrini, Sareh Parangi	87
6	PD-L1 and IDO1 Are Expressed in Poorly Differentiated Thyroid Carcinoma 2018 ·Endocrine Pathology ·Matthew W. Rosenbaum, Benjamin J. Gigliotti, Sara I. Pai, Sareh Parangi, Heather Wachtel, Mari Mino–Kenudson, Viswanath Gunda, William C. Faquin	50
7	Circulating BRAF ^V600E Levels Correlate with Treatment in Patients with Thyroid Carcinoma 2018 ·Thyroid ·Carrie C. Lubitz, Tiannan Zhan, Viswanath Gunda, Salma Amin, Benjamin J. Gigliotti, Abbey Fingeret, Tammy M. Holm, Heather Wachtel, Peter M. Sadow, Lori J. Wirth, Ryan J. Sullivan, David J. Panka, Sareh Parangi	16
8	Inhibition of MAPKinase pathway sensitizes thyroid cancer cells to ABT-737 induced apoptosis 2017 ·Cancer Letters ·Viswanath Gunda, Kristopher A. Sarosiek, Eran Brauner, (unknown), Salma Amin, Zhiheng Zhou, Antony Letai, Sareh Parangi	16
9	Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer 2016 ·Oncotarget ·Eran Brauner, Viswanath Gunda, Pierre Vanden Borre, David Zurakowski, (unknown), (unknown), Salma Amin, Gordon J. Freeman, Sareh Parangi	81
10	Genome-wide analysis of differentially expressed miRNA in PLX4720-resistant and parental human thyroid cancer cell lines 2015 ·Surgery ·Shohreh Varmeh, Pierre Vanden Borre, Viswanath Gunda, Eran Brauner, Tammy M. Holm, (unknown), Ruslan I. Sadreyev, Sareh Parangi	7
11	Detection of Circulating BRAF in Patients with Papillary Thyroid Carcinoma 2015 ·Journal of Molecular Diagnostics ·Carrie C. Lubitz, Sareh Parangi, Tammy M. Holm, (unknown), Aislyn Schalck, Hyunsuk Suh, Konstantinos P. Economopoulos, Viswanath Gunda, (unknown), Peter M. Sadow, Lori J. Wirth, Ryan J. Sullivan, David J. Panka	25
12	Blocks to thyroid cancer cell apoptosis can be overcome by inhibition of the MAPK and PI3K/AKT pathways 2014 ·Cell Death and Disease ·Viswanath Gunda, Octavian Bucur, (unknown), Pierre Vanden Borre, (unknown), Roya Khosravi‐Far, Sareh Parangi	41
13	A Potential Role for Immunotherapy in Thyroid Cancer by Enhancing NY-ESO-1 Cancer Antigen Expression 2014 ·Thyroid ·Viswanath Gunda, Dennie T. Frederick, (unknown), Jennifer A. Wargo, Sareh Parangi	25
14	The Next Generation of Orthotopic Thyroid Cancer Models: Immunocompetent Orthotopic Mouse Models of BRAF ^V600E -Positive Papillary and Anaplastic Thyroid Carcinoma 2013 ·Thyroid ·Pierre Vanden Borre, David G. McFadden, Viswanath Gunda, Peter M. Sadow, Shohreh Varmeh, (unknown), Tyler Jacks, Sareh Parangi	34
15	Potential role of 5-Aza-2′-deoxycytidine induced MAGE-A4 expression in immunotherapy for anaplastic thyroid cancer 2013 ·Surgery ·Viswanath Gunda, Alexandria P. Cogdill, (unknown), Jennifer A. Wargo, Sareh Parangi	23
16	Anti-androgenic endocrine disrupting activities of chlorpyrifos and piperophos 2010 ·The Journal of Steroid Biochemistry and Molecular Biology ·Viswanath Gunda, Shamba Chatterjee, Swati Dabral, Siddharth Nanguneri, (unknown), Partha Roy	94
17	Effects of flavonoid-rich extract from seeds of Eugenia jambolana (L.) on carbohydrate and lipid metabolism in diabetic mice 2008 ·Food Chemistry ·Bhavna Sharma, Viswanath Gunda, Rajani Salunke, Partha Roy	82
18	Detection of potential (anti)progestagenic endocrine disruptors using a recombinant human progesterone receptor binding and transactivation assay 2008 ·Molecular and Cellular Endocrinology ·Viswanath Gunda, Sujata Halder, (unknown), (unknown), Partha Roy	33
19	Androgenic endocrine disruptors in wastewater treatment plant effluents in India: Their influence on reproductive processes and systemic toxicity in male rats 2007 ·Toxicology and Applied Pharmacology ·Vikas Kumar, Ajanta Chakraborty, Viswanath Gunda, Partha Roy	27
20	Assessment of luteinizing hormone receptor function in an endometrial cancer cell line, Ishikawa cells in response to human chorionic gonadotrophin (hCG) 2007 ·Molecular and Cellular Endocrinology ·Viswanath Gunda, Shamba Chatterjee, Partha Roy	11

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact